Digital-to-Biological Converter for On-Demand Production of Biologics Developed by Synthetic Genomics, Inc.

Synthetic Genomics, Inc. announced today the publication of a peer reviewed article describing the development and operation of its digital-to-biological converter (DBC) prototype that produced biologic compounds on-demand without any human intervention. The DBC integrates many of the synthetic biology tools developed by Synthetic Genomics for creating high fidelity and complex synthetic DNA all in one fully automated unit.

Please to read the entire article.